Horizon 2020 research funding has been granted to Syreon Research Institute, as a member of the EU-TOPIA consortium
2017. November 15.
Horizon 2020 research funding was granted to SRI for the 2015-2020 time period, as a member of the EU-TOPIA consortium, led by Erasmus Universitair Medisch Centrum Rotterdam.
The objective of the project, is to systematically evaluate and quantify the harms and benefits of the running programmes for breast, cervical, and colorectal cancer in all European countries, and identify ways to improve health outcomes and equity for citizens.
